Sort by: Article Title Contributor Topic Date
p1_9

Procter & Gamble CEO A.G. Lafley: Lafley’s Law: If You Want to Win Become a Game-Changer

P&G’s A.G. Lafley talks about making real innovation happen.

JP Donlon CEO Interviews July 23 2008

LexisNexis CEO Andy Prozes: Trials and Triumphs

When Andy Prozes took the helm at LexisNexis in 2000, the com pany was the go-to resource for legal records, [...]

Jennifer Pellet CEO Interviews April 22 2008

UBS India Chairperson Manisha Girotra: Scaling India’s M&A Peak

Move over Zoe Cruz. The former co-president of Morgan Stanley, who is or perhaps was the bestknown woman investment banker, [...]

Fayazuddin A. Shirazi CEO Interviews April 22 2008

Hulu CEO Jason Kilar: Hulu Hoopla?

Jason Kilar is underscoring some of the differences between his new online video startup, Hulu, and its corporate parents: NBC [...]

Joe Mccarthy CEO Interviews April 22 2008
p36_4

H. J. Heinz Chairman & CEO Bill Johnson: The Innovation Playbook

Usually when shareholder activists call on a CEO demanding a slate of new board directors, its time to circle the [...]

JP Donlon CEO Interviews , Governance/Compliance , Manufacturing , Strategy March 7 2008

Vodafone Group Plc UK CEO Arun Sarin: Global, Mobile and Growing

After a series of mergers and acquisitions, U.K.-based Vodafone Group Plc now boasts revenues of $61.2 billion, operations in 25 [...]

Chief Executive CEO Interviews , Strategy March 5 2008

Adecco CEO Tig Gilliam: Talent Talk

Business leaders are fond of saying that their best assets leave by elevator every night, a mantra meant to underscore [...]

Jennifer Pellet CEO Interviews January 16 2008

HP CEO Tom Perkins: Kleiner Perkins Partner Tom Kleiner: Valley Voyager

Silicon Valley celeb Tom Perkins is no stranger to the spotlight. An innovator of laser technology-turned-VC, he helped nurture AOL, [...]

Tom Perkin CEO Interviews January 16 2008
p37_1

Novartis CEO Daniel Vasella: That Vasella Fella

Swiss drugmaker Novartis has brought 16 new drugs to market in the U.S. since 2000, compared to 13 for Pfizer and 9 for Merck. Now CEO Daniel Vasella is using biologics as a platform for the next stage of growth.

JP Donlon CEO Interviews November 1 2007
p48_5

AEP Chairman & CEO Mike Morris: Future Power

AEP’s Michael Morris says that like it or not fossil fuels will remain our principal source of energy for much [...]

JP Donlon CEO Interviews September 10 2007

Free Newsletters

Sign up now to receive our free e-newsletters. You can choose to receive our weekly CEO Briefing updates, monthly Entrepreneurial CEO newsletter, and exclusive CEO surveys.